Determination of the efficacy of oral propranolol in the management of retinopathy of prematurity
Design
Two arm parallel group double blind randomized trial with drug intervention and outcome assessment
Settings and conduct
Preterm infants admitted in Al Zahra's neonatal intensive care unit , have eye examination at 4-6 weeks after birth. Infants with the diagnosis of retinopathy of prematurity randomly allocate in two groups(oral propranolol or control group). All neonates will assess for need to laser therapy or Avastin administration at 38 weeks corrected gestation age and they will follow till eye examination is completed. A nurse that doesn't know patient's groups, will record their data.
Participants/Inclusion and exclusion criteria
Inclusion criteria: preterm infants with gestational age less than 32 weeks and birth weight less than 1250, Stage 1 , 2 for retinopathy of prematurity.
Exclusion criteria: cardiovascular diseases, eye anomalies, acute renal failure, intraventricular hemorrhage
Intervention groups
After determination of retinopathy of prematurity in eye examination, infants in intervention group receive oral propranolol 0.5 mg/kg every 8 hours. Drug continues till complete vascularization of retina in eye examination or performing laser therapy.
Infants in control group receive routine care for preterm infants without any drug for retinopathy of prematurity
Main outcome variables
Need to intervention (laser therapy or Avastin administration)
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20100512003915N21
Registration date:2018-11-12, 1397/08/21
Registration timing:retrospective
Last update:2018-11-12, 1397/08/21
Update count:0
Registration date
2018-11-12, 1397/08/21
Registrant information
Name
Manizheh Mostafa Gharehbaghi
Name of organization / entity
Tabriz University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 41 1526 2253
Email address
peirovifara@tbzmed.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2018-04-23, 1397/02/03
Expected recruitment end date
2018-09-22, 1397/06/31
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The efficacy of oral Propranolol in the treatment of the retinopathy of prematurity
Public title
Oral propranolol and retinopathy of prematurity
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Preterm infants with gestational age of less than 30 weeks
Birth weight less than 1250 grams
Stage 1 or 2 for retinopathy of prematurity
Exclusion criteria:
Infants with congenital anomalies
Congenital or acquired cardiovascular disease in neonate
Acute renal failure
Severe intra-ventricular hemorrhage
Age
From 28 days old to 120 days old
Gender
Both
Phase
2-3
Groups that have been masked
Participant
Investigator
Outcome assessor
Data analyser
Sample size
Target sample size:
72
Randomization (investigator's opinion)
Randomized
Randomization description
Seventy two preterm infants who met inclusion criteria and the diagnosis of retinopathy of prematurity confirms by ophthalmologist in eye examination, will randomly allocate in control and intervention groups by random numbers generated by random number generator. Ophthalmologist that performs eye examination and a nurse who records patients data are blind about patients groups and their received drugs.
Blinding (investigator's opinion)
Double blinded
Blinding description
Eye examiner ophthalmologist is not involved in medical management of neonates and isn't aware about patients received drugs. patients allocate to groups with respect to propranolol with coding and the nurse who records patients' data is blind to their groups.
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Ethic Committee of Tabriz University of Medical Sciences
Street address
Central University Building, Golghasht St.
City
Tabriz
Province
East Azarbaijan
Postal code
5168636883
Approval date
2018-04-23, 1397/02/03
Ethics committee reference number
IR.TBZMED.REC.1397.101
Health conditions studied
1
Description of health condition studied
Retinopathy of prematurity
ICD-10 code
H35.1
ICD-10 code description
Retinopathy of prematurity
Primary outcomes
1
Description
The need to intervention (laser therapy or Avastin administration) in retinopathy of prematurity
Timepoint
Corrected gestational age 38 weeks (gestational age plus age after birth in weeks)
Method of measurement
Ophthalmoscopic eye examination and performing laser therapy or Avastin administration
Secondary outcomes
empty
Intervention groups
1
Description
Intervention group: We start treatment with oral propranolol ( Osve, Iran) 0.5 mg/kg every 8 hr after detection of retinopathy of prematurity in first eye examination. Drug administration will continue till corrected gestational age of 38 weeks.
Category
Treatment - Drugs
2
Description
Control group receive routine care for preterm infants.
Category
Treatment - Other
Recruitment centers
1
Recruitment center
Name of recruitment center
NICU. Alzahra hospital
Full name of responsible person
Mina Hosseini
Street address
NICU, Al Zahra Hospital, South Artesh St.
City
Tabriz
Province
East Azarbaijan
Postal code
5136688449
Phone
+98 41 3553 9161
Email
Ehsasatme2000@yahoo.com
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Tabriz University of Medical Sciences
Full name of responsible person
Dr Abolghasem Juiban
Street address
Central University building, Golgasht st.
City
Tabriz
Province
East Azarbaijan
Postal code
5168636883
Phone
+98 41 3335 7310
Email
research-vice@tbzmed.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Tabriz University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Tabriz University of Medical Sciences
Full name of responsible person
Mina Hosseini
Position
fellowship of neonatology
Latest degree
Specialist
Other areas of specialty/work
Pediatrics
Street address
NICU, Al Zahra hospital, South Artesh St.
City
Tabriz
Province
East Azarbaijan
Postal code
5136688449
Phone
+98 41 3553 9161
Email
Ehsasatme2000@yahoo.com
Person responsible for scientific inquiries
Contact
Name of organization / entity
Tabriz University of Medical Sciences
Full name of responsible person
Mina Hosseini
Position
Fellowship
Latest degree
Specialist
Other areas of specialty/work
Pediatrics
Street address
NICU, Alzahra hospital, South Artesh St.
City
Tabriz
Province
East Azarbaijan
Postal code
5136688449
Phone
+98 41 3553 9161
Email
Ehsasatme2000@yahoo.com
Person responsible for updating data
Contact
Name of organization / entity
Tabriz University of Medical Sciences
Full name of responsible person
Mina Hosseini
Position
fellowship
Latest degree
Specialist
Other areas of specialty/work
Pediatrics
Street address
NICU, Alzahra Hospital, South Artesh St.
City
Tabriz
Province
East Azarbaijan
Postal code
5136688449
Phone
+98 35539161
Email
Ehsasatme2000@yahoo.com
Sharing plan
Deidentified Individual Participant Data Set (IPD)
No - There is not a plan to make this available
Justification/reason for indecision/not sharing IPD
There is no further information
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
No - There is not a plan to make this available
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available